Skip to main content
Clinical Trials/CTRI/2020/05/025064
CTRI/2020/05/025064
Recruiting
未知

Role of Albumin versus Plasmalyte A salt solution in improving Major Adverse Kidney Events within 30 days (MAKE30) in critically ill cirrhotic patients with sepsis- A Pilot Study.

Post Graduate Medical Education and Research Chandigarh0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K77- Liver disorders in diseases classified elsewhere
Sponsor
Post Graduate Medical Education and Research Chandigarh
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Post Graduate Medical Education and Research Chandigarh

Eligibility Criteria

Inclusion Criteria

  • 1\)Adults ( \>18 years) admitted to ICU with cirrhosis and sepsis
  • 2\)Hypotension (Mean Arterial Pressure (MAP) \<65mmHg)
  • 3\)Lactate levels \>2 mmol/L (to pick even mild hypoperfusion)
  • 4\)Clinical need for of a Central Venous Catheter (CVC) and arterial line

Exclusion Criteria

  • 1\)Severe pre\-existing cardiopulmonary disease
  • 2\)Active bleeding
  • 3\)Cerebrovascular events
  • 4\)Prior renal disease/need of renal replacement therapy
  • 5\)Admission to ICU following liver transplantation, burns, cardiac surgery
  • 6\)Brain death or likely brain death within 24 hours
  • 7\)Previous adverse reaction to human albumin solution

Outcomes

Primary Outcomes

Not specified

Similar Trials